Telemedicine for Postoperative Follow-up After Oncological Surgeries

Launched by INSTITUTO DO CANCER DO ESTADO DE SÃO PAULO · Feb 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the use of telemedicine for follow-up care after surgeries for urologic cancers. Essentially, it aims to find out if using virtual appointments instead of in-person visits is just as effective for patients recovering from these surgeries. The study will take place at the Cancer Institute of the State of São Paulo over six months, and patients who agree to participate will need to sign a consent form.

To be eligible for this trial, patients should be between the ages of 65 and 74 and have had certain types of surgeries related to urologic cancers, such as prostate or bladder procedures. However, those who had emergency surgeries or major procedures, or who require special equipment like drains, will not be included. Participants can expect to engage in follow-up care through telemedicine, which means they can have their check-ups from the comfort of their home. This trial is important because it may help improve patient satisfaction by making follow-up care easier and more accessible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients with urological neoplasms who have undergone low and medium complexity surgical procedures (e.g. prostate TUR, Bladder TURP, double-J passage, partial or total nephrectomy videolaparoscopic and open) at ICESP
• Exclusion Criteria:
• • All patients undergoing emergency operations, outpatient procedures, major procedures, patients with probes or drains or no support for home telemedicine